Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print November 14, 2007.
Biol Reprod 2007, 10.1095/biolreprod.107.064089
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
78/3/380    most recent
biolreprod.107.064089v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Walters, K.A.
Right arrow Articles by Handelsman, D.J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walters, K.A.
Right arrow Articles by Handelsman, D.J.
Agricola
Right arrow Articles by Walters, K.A.
Right arrow Articles by Handelsman, D.J.
BIOLOGY OF REPRODUCTION 78, 380–389 (2008)
DOI: 10.1095/biolreprod.107.064089
© 2008 by the Society for the Study of Reproduction, Inc.

Androgen Actions and the Ovary

K.A. Walters , C.M. Allan , and D.J. Handelsman 1

Andrology Laboratory, ANZAC Research Institute, Concord Hospital, University of Sydney, New South Wales 2139, Australia

ABSTRACT

Although androgens and the androgen receptor (AR) have defining roles in male reproductive development and function, previously no role in female reproductive physiology beyond testosterone (T) as the precursor in estradiol (E2) biosynthesis was firmly established. Understanding the role and specific mechanisms of androgen action via the AR in the ovary has been limited by confusion on how to interpret results from pharmacological studies, because many androgens can be metabolized in vivo and in vitro to steroids that can also exert actions via the estrogen receptor (ESR). Recent genetic studies using mouse models with specific disruption of the Ar gene have highlighted the role that AR-mediated actions play in maintaining female fertility through key roles in the regulation of follicle health, development, and ovulation. Furthermore, these genetic studies have revealed that AR-mediated effects influence age-related female fertility, possibly via mechanisms acting predominantly at the hypothalamic-pituitary axis in a dose-dependent manner. This review focuses on combining the findings from pharmacological studies and novel genetic mouse models to unravel the roles of ovarian androgen actions in relation to female fertility and ovarian aging, as well as creating new insights into the role of androgens in androgen-associated reproductive disorders such as polycystic ovarian syndrome.

androgen receptor, fertility, follicular development, ovary


Correspondence: 1David J. Handelsman, ANZAC Research Institute, Sydney, NSW 2139, Australia. FAX: 61 2 9767 9101; e-mail: djh{at}anzac.edu.au







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for the Study of Reproduction.